AW
CYTK icon

Avion Wealth’s Cytokinetics CYTK Stock Holding History

Avion Wealth’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3K Buy
36
+6
+20% +$431 ﹤0.01% 930
2026
Q1 		$1K Hold
30
– – ﹤0.01% 1002
2025
Q4 		$1K Sell
30
-6
-17% -$373 ﹤0.01% 1001
2025
Q3 		$1K Buy
36
+24
+200% +$989 ﹤0.01% 988
2025
Q2 		$0 Buy
+12
New +$417 ﹤0.01% 1260

Other funds holding CYTK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Avion Wealth's CYTK Position: Q2 2026 in Review

Avion Wealth increased its Cytokinetics (CYTK) stake by 20% in Q2 2026, buying an estimated $431 and bringing the position to 36 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #930.

Avion Wealth first reported a position in CYTK in Q2 2025 and has held it in 5 quarters since. 482 funds tracked by Wall St. Rank hold CYTK as of Q2 2026.

  • Avion Wealth held 36 shares of Cytokinetics worth $3K as of Q2 2026.
  • Avion Wealth bought 6 Cytokinetics shares in Q2 2026, an estimated $431.
  • Cytokinetics made up ﹤0.01% of Avion Wealth's portfolio in Q2 2026, its #930 holding.
  • Avion Wealth first reported a position in Cytokinetics in Q2 2025 and has held it in 5 quarters since.
  • 482 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2026.

Based on Avion Wealth's 13F filing for Q2 2026, filed 31 Jul 2026.